NKGen Biotech, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2021 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
NKGen Biotech, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2021 to Q3 2024.
  • NKGen Biotech, Inc. Entity Common Stock, Shares Outstanding for the quarter ending September 12, 2024 was 35.4M shares, a 61.6% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 35.4M +13.5M +61.6% Sep 12, 2024 10-Q 2024-09-12
Q2 2024 24.9M +14.5M +140% May 20, 2024 10-Q 2024-05-20
Q1 2024 22.8M +1.35M +6.31% Apr 16, 2024 10-K 2024-04-16
Q3 2023 21.9M +437K +2.04% Nov 13, 2023 10-Q 2023-11-14
Q2 2023 10.4M -11.1M -51.6% Aug 14, 2023 10-Q 2023-08-14
Q1 2023 21.5M 0 0% Mar 31, 2023 10-K 2023-03-31
Q3 2022 21.5M Nov 14, 2022 10-Q 2022-11-14
Q2 2022 21.5M +1K +0.01% May 16, 2022 10-Q 2022-05-16
Q1 2022 21.5M Mar 30, 2022 10-K 2022-03-31
Q4 2021 21.5M Jan 31, 2022 10-Q/A 2022-01-31
Q2 2021 21.5M Jul 2, 2021 10-Q 2021-07-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.